牛叉诊股

[{"date":"2023.03.30","stock":"1.08","trade":"-0.83","ind":"0.62"},{"date":"2023.03.29","stock":"1.16","trade":"0.01","ind":"0.13"},{"date":"2023.03.28","stock":"3.84","trade":"1.45","ind":"-0.72"},{"date":"2023.03.27","stock":"0.53","trade":"-0.11","ind":"0.12"},{"date":"2023.03.24","stock":"-4.14","trade":"-2.15","ind":"0.25"},{"date":"2023.03.23","stock":"0.58","trade":"-0.31","ind":"0.94"},{"date":"2023.03.22","stock":"-2.91","trade":"-0.05","ind":"0.61"},{"date":"2023.03.21","stock":"0.64","trade":"0.91","ind":"1.60"},{"date":"2023.03.20","stock":"-0.99","trade":"-2.36","ind":"-0.27"},{"date":"2023.03.17","stock":"-2.01","trade":"-1.46","ind":"0.36"},{"date":"2023.03.16","stock":"3.59","trade":"0.54","ind":"-1.54"},{"date":"2023.03.15","stock":"13.24","trade":"3.20","ind":"-0.03"},{"date":"2023.03.14","stock":"-3.45","trade":"-2.26","ind":"-0.77"},{"date":"2023.03.13","stock":"3.32","trade":"1.91","ind":"0.55"},{"date":"2023.03.10","stock":"-3.82","trade":"-1.25","ind":"-1.19"},{"date":"2023.03.09","stock":"1.26","trade":"0.74","ind":"-0.16"},{"date":"2023.03.08","stock":"0.16","trade":"0.29","ind":"-0.09"},{"date":"2023.03.07","stock":"-1.48","trade":"-2.09","ind":"-1.98"},{"date":"2023.03.06","stock":"5.42","trade":"0.94","ind":"-0.08"},{"date":"2023.03.03","stock":"1.08","trade":"-0.25","ind":"0.02"},{"date":"2023.03.02","stock":"-2.51","trade":"-1.40","ind":"-0.54"}]

佐力药业,深证成指,中药指数

压力支撑

该股压力位为13.79元，支撑位为13.46元。

[{"text":"\u538b\u529b\u4f4d","value":"13.79","date":1680105600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.46","date":1680105600,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.0资金面打败了46%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：03月31日 08:07

机构今日流向(万元)	-946.15	机构5日流向(万元)	-5144.86
机构10日流向(万元)	-12394.06	机构20日流向(万元)	-14490.28

机构持仓

2022-12-31 与 2022-06-30 相比，主力机构持仓量减少7266.23万股，其中基金净增仓4家，主力净减仓74家，暂未发现中长期投资价值。

截止2022-12-31，共21家主力机构（基金21家），持仓量总计1014.54万股，占流通A股1.67%
其中，基金持仓与2022-06-30相比：
增仓：6家，增持 365.20万股
减仓：2家，减持 24.19万股
新出现在主力名单中：13家，持有293.34万股
从主力名单中消失：87家，原持有7900.58万股

消息面诊股

诊断结果：7.5消息面打败了94%的股票今日有利好新闻的公司

近期利好消息较多且有重大利好，消息面发出积极信号。

消息面得分最高的股票

消息列表

重大利好	业绩预告	业绩大幅上升	2023-03-15
一般消息	募资投向		2023-03-14
重大利好	业绩预告	业绩大幅上升	2023-01-20
一般消息	高管变动	因工作调整	2023-01-03
一般消息	股东大会	临时股东大会	2022-12-17
利好	股票增发	已实施	2022-11-15
一般消息	分红转增	不分配不转增	2022-08-30
一般消息	重大事项	关联交易	2022-05-17
利好	分红转增	10派2元(含税)	2022-04-20
一般消息	高管变动	因退休原因	2022-04-19

一年消息统计

	所有消息	重大消息	非重大消息
利好	4条	2条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：5.2行业面打败了56%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2023.03.30","price":"0.62","value":"-0.83"},{"date":"2023.03.29","price":"0.13","value":"0.01"},{"date":"2023.03.28","price":"-0.72","value":"1.45"},{"date":"2023.03.27","price":"0.12","value":"-0.11"},{"date":"2023.03.24","price":"0.25","value":"-2.15"},{"date":"2023.03.23","price":"0.94","value":"-0.31"},{"date":"2023.03.22","price":"0.61","value":"-0.05"},{"date":"2023.03.21","price":"1.60","value":"0.91"},{"date":"2023.03.20","price":"-0.27","value":"-2.36"},{"date":"2023.03.17","price":"0.36","value":"-1.46"},{"date":"2023.03.16","price":"-1.54","value":"0.54"},{"date":"2023.03.15","price":"-0.03","value":"3.20"},{"date":"2023.03.14","price":"-0.77","value":"-2.26"},{"date":"2023.03.13","price":"0.55","value":"1.91"},{"date":"2023.03.10","price":"-1.19","value":"-1.25"},{"date":"2023.03.09","price":"-0.16","value":"0.74"},{"date":"2023.03.08","price":"-0.09","value":"0.29"},{"date":"2023.03.07","price":"-1.98","value":"-2.09"},{"date":"2023.03.06","price":"-0.08","value":"0.94"},{"date":"2023.03.03","price":"0.02","value":"-0.25"},{"date":"2023.03.02","price":"-0.54","value":"-1.40"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	太极集团	760.71%	9.95%	5.6分
2	盘龙药业	177.25%	0.29%	5.6分
3	健民集团	18.44%	7.99%	4.8分
4	佐力药业	16.93%	2.32%	6.0分
5	江中药业	15.55%	4.68%	5.4分
6	桂林三金	13.90%	5.09%	6.0分
7	方盛制药	12.45%	1.82%	4.5分
8	达仁堂	10.85%	2.80%	5.0分
9	康恩贝	10.56%	-1.37%	4.4分
10	同仁堂	9.98%	5.77%	5.6分
11	东阿阿胶	9.49%	13.78%	6.4分
12	华润三九	7.96%	3.24%	5.7分
13	九芝堂	4.91%	-2.70%	4.7分
14	千金药业	4.91%	-3.39%	4.5分
15	-	4.39%	4.39%	分
16	珍宝岛	3.34%	2.70%	4.7分
17	昆药集团	3.20%	0.99%	4.8分
18	西藏药业	1.60%	5.46%	4.8分
19	贵州三力	1.15%	3.41%	5.4分
20	寿仙谷	-0.34%	-2.29%	4.4分
21	奇正藏药	-0.64%	0.40%	4.9分
22	信邦制药	-1.00%	-1.78%	5.5分
23	新光药业	-1.28%	-1.39%	3.9分
24	沃华医药	-2.26%	-3.71%	5.1分
25	益佰制药	-2.47%	-2.30%	3.9分
26	嘉应制药	-2.67%	1.19%	5.4分
27	马应龙	-2.67%	-2.05%	4.5分
28	白云山	-3.35%	-0.76%	4.5分
29	吉林敖东	-3.38%	-1.37%	4.3分
30	中恒集团	-3.62%	-2.21%	4.0分
31	ST康美	-3.70%	-3.26%	3.9分
32	恩威医药	-4.08%	-2.14%	4.5分
33	济川药业	-4.80%	-2.29%	4.3分
34	广誉远	-5.00%	1.60%	3.9分
35	仁和药业	-5.16%	-1.57%	4.4分
36	云南白药	-5.68%	0.30%	5.2分
37	陇神戎发	-5.69%	-2.98%	3.7分
38	汉森制药	-5.90%	-3.12%	4.3分
39	华神科技	-6.49%	-2.54%	4.3分
40	以岭药业	-6.90%	-2.03%	4.5分
41	葫芦娃	-7.25%	2.06%	4.0分
42	金花股份	-7.29%	-1.99%	4.4分
43	益盛药业	-7.48%	-3.77%	3.9分
44	康惠制药	-7.69%	-3.24%	3.2分
45	万邦德	-8.09%	-4.88%	4.2分
46	维康药业	-8.76%	-3.63%	4.3分
47	启迪药业	-9.10%	-5.50%	4.0分
48	片仔癀	-9.57%	-0.36%	4.5分
49	贵州百灵	-9.61%	-5.05%	4.3分
50	红日药业	-9.66%	-6.75%	3.7分
51	莱茵生物	-10.02%	-6.79%	4.3分
52	葵花药业	-10.06%	-11.88%	4.5分
53	华森制药	-11.04%	-5.23%	3.7分
54	香雪制药	-11.44%	-5.41%	4.0分
55	众生药业	-11.45%	-1.81%	4.9分
56	龙津药业	-11.65%	-4.47%	3.2分
57	大理药业	-11.66%	-5.08%	3.9分
58	ST目药	-12.29%	-5.48%	3.8分
59	粤万年青	-12.32%	-4.97%	3.4分
60	新天药业	-13.66%	-5.48%	4.5分
61	精华制药	-13.84%	-5.25%	4.1分
62	紫鑫药业	-14.78%	-5.31%	4.0分
63	长药控股	-16.25%	-5.51%	4.3分
64	上海凯宝	-17.75%	-4.49%	4.1分
65	特一药业	-20.78%	-6.85%	4.5分
66	-	-21.92%	-3.26%	分
67	ST太安	-22.27%	-6.68%	4.5分
68	步长制药	-	-1.74%	4.2分
69	康缘药业	-	3.24%	5.8分
70	天士力	-	-5.14%	5.0分
71	亚宝药业	-	-2.13%	4.9分
72	羚锐制药	-	-0.99%	4.8分
73	太龙药业	-	-4.98%	4.8分
74	*ST吉药	-	-4.12%	4.3分
75	佛慈制药	-	-4.55%	5.6分

<上一页 1 2 3 4 5...13 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：7.7基本面打败了97%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（70分）

基本面得分最高的股票

[ 截止日期：2022-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 12/124 ， 15/124。

[{"date":"2022-09-30","value":"11.58","vol":"4.66"},{"date":"2022-06-30","value":"7.70","vol":"3.30"},{"date":"2022-03-31","value":"3.86","vol":"1.97"},{"date":"2021-12-31","value":"10.41","vol":"6.78"},{"date":"2021-09-30","value":"6.83","vol":"7.14"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
净资产收益率(%)	11.58	7.70	3.86	10.41	6.83
行业(%)	4.66	3.30	1.97	6.78	7.14

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2022-09-30","value":"71.34","vol":"54.62"},{"date":"2022-06-30","value":"70.92","vol":"54.66"},{"date":"2022-03-31","value":"72.01","vol":"54.23"},{"date":"2021-12-31","value":"71.43","vol":"54.90"},{"date":"2021-09-30","value":"71.43","vol":"55.55"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
销售毛利率(%)	71.34	70.92	72.01	71.43	71.43
行业(%)	54.62	54.66	54.23	54.90	55.55

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 7/124 ， 6/124。

[{"date":"2022-09-30","value":"24.66","vol":"2.88"},{"date":"2022-06-30","value":"28.28","vol":"1.92"},{"date":"2022-03-31","value":"29.18","vol":"3.18"},{"date":"2021-12-31","value":"33.60","vol":"11.86"},{"date":"2021-09-30","value":"40.14","vol":"17.66"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
营业收入同比增长率(%)	24.66	28.28	29.18	33.60	40.14
行业(%)	2.88	1.92	3.18	11.86	17.66

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2022-09-30","value":"55.08","vol":"-26.10"},{"date":"2022-06-30","value":"55.83","vol":"-14.45"},{"date":"2022-03-31","value":"56.97","vol":"-27.17"},{"date":"2021-12-31","value":"102.03","vol":"-83.89"},{"date":"2021-09-30","value":"110.87","vol":"247.58"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
净利润同比增长率(%)	55.08	55.83	56.97	102.03	110.87
行业(%)	-26.10	-14.45	-27.17	-83.89	247.58

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/124 ， 48/124。

[{"date":"2022-09-30","value":"0.51","vol":"0.39"},{"date":"2022-06-30","value":"0.34","vol":"0.26"},{"date":"2022-03-31","value":"0.17","vol":"0.13"},{"date":"2021-12-31","value":"0.56","vol":"0.55"},{"date":"2021-09-30","value":"0.37","vol":"0.41"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
总资产周转率(次)	0.51	0.34	0.17	0.56	0.37
行业(次)	0.39	0.26	0.13	0.55	0.41

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2022-09-30","value":"1.39","vol":"1.98"},{"date":"2022-06-30","value":"0.95","vol":"1.32"},{"date":"2022-03-31","value":"0.47","vol":"0.65"},{"date":"2021-12-31","value":"1.75","vol":"2.76"},{"date":"2021-09-30","value":"1.49","vol":"1.96"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
存货增长率(次)	1.39	0.95	0.47	1.75	1.49
行业(次)	1.98	1.32	0.65	2.76	1.96

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2022-09-30","value":"13.72","vol":"6.85"},{"date":"2022-06-30","value":"10.21","vol":"18.46"},{"date":"2022-03-31","value":"19.51","vol":"7.17"},{"date":"2021-12-31","value":"17.37","vol":"11.46"},{"date":"2021-09-30","value":"24.26","vol":"-8.64"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
现金流量净额/营业收入	13.72	10.21	19.51	17.37	24.26
行业	6.85	18.46	7.17	11.46	-8.64

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2022-09-30","value":"","vol":"0.00"},{"date":"2022-06-30","value":"3.19","vol":"1.71"},{"date":"2022-03-31","value":"","vol":"0.00"},{"date":"2021-12-31","value":"2.48","vol":"1.81"},{"date":"2021-09-30","value":"","vol":"0.00"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
资本支出／折旧和摊销	-	3.19	-	2.48	-
行业	0.00	1.71	0.00	1.81	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 31/124 ， 1/124。

[{"date":"2022-09-30","value":"1.41","vol":"2.90"},{"date":"2022-06-30","value":"1.47","vol":"2.87"},{"date":"2022-03-31","value":"1.63","vol":"2.96"},{"date":"2021-12-31","value":"1.61","vol":"2.96"},{"date":"2021-09-30","value":"1.69","vol":"2.99"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
流动比率	1.41	1.47	1.63	1.61	1.69
行业	2.90	2.87	2.96	2.96	2.99

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2022-09-30","value":"1.00","vol":"2.18"},{"date":"2022-06-30","value":"1.03","vol":"2.16"},{"date":"2022-03-31","value":"1.20","vol":"2.27"},{"date":"2021-12-31","value":"1.13","vol":"2.33"},{"date":"2021-09-30","value":"1.26","vol":"2.32"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
速动比率	1.00	1.03	1.20	1.13	1.26
行业	2.18	2.16	2.27	2.33	2.32

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 30/124 ， 34/124。

[{"date":"2022-09-30","value":"31.97","vol":"33.83"},{"date":"2022-06-30","value":"29.75","vol":"33.87"},{"date":"2022-03-31","value":"27.64","vol":"32.82"},{"date":"2021-12-31","value":"27.84","vol":"33.27"},{"date":"2021-09-30","value":"27.08","vol":"33.65"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
资产负债率(%)	31.97	29.75	27.64	27.84	27.08
行业(%)	33.83	33.87	32.82	33.27	33.65

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2022-09-30","value":"0.48","vol":"0.88"},{"date":"2022-06-30","value":"0.45","vol":"0.81"},{"date":"2022-03-31","value":"0.41","vol":"0.71"},{"date":"2021-12-31","value":"0.41","vol":"0.70"},{"date":"2021-09-30","value":"0.40","vol":"0.62"}]

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
产权比率 (%)	0.48	0.45	0.41	0.41	0.40
行业(%)	0.88	0.81	0.71	0.70	0.62

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
光大证券	2023-03-15	买入
长城证券	2023-03-15	买入	买入
国海证券	2023-01-30	买入

机构预测

机构预测该股2022年每股收益与前一年相同，长期投资价值一般。

[{"date":"2018","yellowRectValue":"0.21","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"0.26","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"0.89","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"1.79","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.67","blueLineValue":"0.38","type":"YC"}]

[佐力药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]